The Wistar Institute-医療機器分野:企業M&A・提携分析

◆英語タイトル:The Wistar Institute - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011302
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training in cancer, infectious diseases, immunology and vaccine development. The institute conducts research on genes, gene expression, and DNA biology; cancer biology; translational research; and virology. It develops vaccines against rotavirus, rabies, and rubella; the identification of genes associated with breast, lung, prostate and other cancers; and the development of monoclonal antibodies and other research technologies and tools. Wista offers postdoctoral, predoctoral, and high school programs in biomedical research. The institute works in partnership with University of Pennsylvania, Children’s Hospital of Philadelphia, and Temple University and other research organizations. Wistar is headquartered in Philadelphia, Pennsylvania, the US.

The Wistar Institute – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Wistar Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
The Wistar Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 6
The Wistar Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
The Wistar Institute, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
The Wistar Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
The Wistar Institute, Medical Equipment, Deal Details 10
Partnerships 10
Anixa Diagnostics Enters into Research Agreement with Wistar Institute 10
OncoCyte Expands Co-Development Agreement with Wistar Institute 11
ITUS Enters into Licensing Agreement with Wistar Institute 12
The Wistar Institute – Key Competitors 13
The Wistar Institute – Key Employees 14
The Wistar Institute – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jun 29, 2016: The Wistar Institute Names Jeff Fahnoe Chief Information Officer 16
Product News 17
Oct 24, 2016: OncoCyte Announces Sponsored Symposium at the 2016 American College of Chest Physician’s CHEST 2016 Annual Meeting 17
Other Significant Developments 18
Mar 03, 2017: Wistar’S Qihong Huang, M.D., Ph.D., Receives $50K Grant From The PA Breast Cancer Coalition For Novel Therapeutic Approach For Metastatic Breast Cancer 18
May 17, 2016: Wistar Research Teams Awarded More Than $6.5 Million in Funding 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
The Wistar Institute, Medical Equipment, Key Facts 2
The Wistar Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
The Wistar Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
The Wistar Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 6
The Wistar Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
The Wistar Institute, Deals By Market, 2011 to YTD 2017 8
The Wistar Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Anixa Diagnostics Enters into Research Agreement with Wistar Institute 10
OncoCyte Expands Co-Development Agreement with Wistar Institute 11
ITUS Enters into Licensing Agreement with Wistar Institute 12
The Wistar Institute, Key Competitors 13
The Wistar Institute, Key Employees 14

★海外企業調査レポート[The Wistar Institute-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sermonix Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company’s lead product include lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting women that …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Talisman Mining Ltd (TLM):企業の財務・戦略的SWOT分析
    Summary Talisman Mining Ltd (Talisman Mining) is a mining and mineral exploration and development company. The company explores for copper-gold, base metal, and gold deposits. Its projects portfolio includes Springfield project, Sinclair Nickel Project, Milgun Project, Halloween and Halloween West J …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Takeuchi Mfg. Co Ltd
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intraco Ltd (I06):企業の財務・戦略的SWOT分析
    Intraco Ltd (I06) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mayo Clinic:医療機器:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • EnBW Energie Baden-Wurttemberg AG (EBK):電力:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Southern Co (SO)-エネルギー分野:企業M&A・提携分析
    Summary Southern Company (Southern Company) is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distribut …
  • Teleflex Incorporated:戦略・SWOT・企業財務分析
    Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary China National Petroleum Corporation (CNPC) is an integrated oil and gas company that produces and supplies oil and gas and petrochemical products. The company explores, develops and produces hydrocarbons in onshore and offshore areas of China, Canada, Africa, Central Asia and Russia, Latin …
  • AB-Biotics SA (ABB)-製薬・医療分野:企業M&A・提携分析
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, specialty dietary supplements, pipeline products and other functional ingredients. The company’s products comprise probiotic products, iron-containing ingredients, lactobacillus plantarum, lactobacillus brevis, natural solutions, gastro …
  • ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary ALS Therapy Development Institute (ALS TDI), formerly ALS Therapy Development Foundation, is a drug discovery center that offers research and healthcare services. The center's pipeline product include AT-1501, a novel antibody therapeutic that blocks specific immune cell activation and prote …
  • Rabigh Refining & Petrochemical Co (2380):企業の財務・戦略的SWOT分析
    Rabigh Refining & Petrochemical Co (2380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • MOL Hungarian Oil and Gas PLC (MOL)-石油・ガス分野:企業M&A・提携分析
    Summary MOL Hungarian Oil and Gas Public Limited Company (MOL) is an integrated oil and gas company. It explores develops and produces crude oil, natural gas. It conducts refining, transportation and storage of crude oil; wholesale and retail marketing of crude oil products, production and sale of p …
  • Piramal Glass Pvt Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bain & Company, Inc.:戦略・SWOT・企業財務分析
    Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆